(Q47301630)

13 January 2018

meta-analysis

0 references

title

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis (English)

1 reference

13 January 2018

1 reference

1 reference

Andrea de Bartolomeis

object named as

Andrea de Bartolomeis

3

1 reference

ORCID Public Data File 2021

author name string

Vincenzo De Luca

1

1 reference

13 January 2018

Daniel J Mueller

2

1 reference

13 January 2018

James L Kennedy

4

1 reference

13 January 2018

publication date

12 February 2007

1 reference

13 January 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

13 January 2018

volume

10

1 reference

13 January 2018

issue

5

1 reference

13 January 2018

page(s)

697-704

1 reference

13 January 2018

The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Meta-analysis and the meta-epidemiology of clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Decrease of serotonin receptor 2C in schizophrenia brains identified by high-resolution mRNA expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Serotonin receptor 2C (HTR2C) and schizophrenia: examination of possible medication and genetic influences on expression levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Pharmacogenomics in schizophrenia: the quest for individualized therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

A prospective study of holiday weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Pharmacogenetics as a tool in the therapy of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Bodyweight gain with atypical antipsychotics. A comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Pharmacogenetics of antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Genetic variants of the serotonin system and weight change during clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

-759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Establishment of genetic associations for complex diseases is independent of early study findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

Pharmacogenetics of antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

7 January 2021

Antipsychotics and diabetes: review of non-prospective data.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

7 January 2021

Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

7 January 2021

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007547

7 January 2021

10.1017/S1461145707007547

Identifiers

DOI

0 references

1 reference

13 January 2018